Phase IIa cross-over study of propylene glycol-free melphalan (LGD-353) and alkeran in multiple myeloma autologous transplantation.
about
High melphalan exposure is associated with improved overall survival in myeloma patients receiving high dose melphalan and autologous transplantation.Melphalan hydrochloride for the treatment of multiple myeloma.Population Pharmacokinetics and Optimal Sampling Strategy for Model-Based Precision Dosing of Melphalan in Patients Undergoing Hematopoietic Stem Cell Transplantation.
P2860
Phase IIa cross-over study of propylene glycol-free melphalan (LGD-353) and alkeran in multiple myeloma autologous transplantation.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Phase IIa cross-over study of ...... ma autologous transplantation.
@en
Phase IIa cross-over study of propylene glycol-free melphalan
@nl
type
label
Phase IIa cross-over study of ...... ma autologous transplantation.
@en
Phase IIa cross-over study of propylene glycol-free melphalan
@nl
prefLabel
Phase IIa cross-over study of ...... ma autologous transplantation.
@en
Phase IIa cross-over study of propylene glycol-free melphalan
@nl
P2093
P2860
P356
P1476
Phase IIa cross-over study of ...... ma autologous transplantation.
@en
P2093
J D Pipkin
J P McGuirk
O S Aljitawi
S H Abhyankar
P2860
P2888
P304
P356
10.1038/BMT.2014.120
P407
P577
2014-06-09T00:00:00Z
P5875
P6179
1040827616